Literature DB >> 22213089

Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study.

Mijke M M Verhagen1, James I Last, Frans B L Hogervorst, Dominique F C M Smeets, Nel Roeleveld, Frans Verheijen, Coriene E Catsman-Berrevoets, Nico M Wulffraat, Jan M Cobben, Johan Hiel, Ewout R Brunt, Els A J Peeters, Encarna B Gómez Garcia, Marjo S van der Knaap, Carsten R Lincke, Laura A E M Laan, Marina A J Tijssen, Monique A van Rijn, Danielle Majoor-Krakauer, Marjan Visser, Laura J van 't Veer, Wim J Kleijer, Bart P C van de Warrenburg, Adilia Warris, Imelda J M de Groot, Ronald de Groot, Annegien Broeks, Frank Preijers, Berry H P H Kremer, Corry M R Weemaes, Malcolm A M R Taylor, Marcel van Deuren, Michèl A A P Willemsen.   

Abstract

Ataxia-telangiectasia (A-T) is an autosomal recessive neurodegenerative disorder with multisystem involvement and cancer predisposition, caused by mutations in the A-T mutated (ATM) gene. To study genotype-phenotype correlations, we evaluated the clinical and laboratory data of 51 genetically proven A-T patients, and additionally measured ATM protein expression and kinase activity. Patients without ATM kinase activity showed the classical phenotype. The presence of ATM protein, correlated with slightly better immunological function. Residual kinase activity correlated with a milder and essentially different neurological phenotype, absence of telangiectasia, normal endocrine and pulmonary function, normal immunoglobulins, significantly lower X-ray hypersensitivity in lymphocytes, and extended lifespan. In these patients, cancer occurred later in life and generally consisted of solid instead of lymphoid malignancies. The genotypes of severely affected patients generally included truncating mutations resulting in total absence of ATM kinase activity, while patients with milder phenotypes harbored at least one missense or splice site mutation resulting in expression of ATM with some kinase activity. Overall, the phenotypic manifestations in A-T show a continuous spectrum from severe classical childhood-onset A-T to a relatively mild adult-onset disorder, depending on the presence of ATM protein and kinase activity. Each patient is left with a tremendously increased cancer risk.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22213089     DOI: 10.1002/humu.22016

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  47 in total

1.  A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.

Authors:  Andrew Campbell; Brittany Krupp; Jared Bushman; Mark Noble; Christoph Pröschel; Margot Mayer-Pröschel
Journal:  Hum Mol Genet       Date:  2015-08-26       Impact factor: 6.150

2.  Genomic profiling of Acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis.

Authors:  M Ratnaparkhe; M Hlevnjak; T Kolb; A Jauch; K K Maass; F Devens; A Rode; V Hovestadt; A Korshunov; A Pastorczak; W Mlynarski; S Sungalee; J Korbel; J Hoell; U Fischer; T Milde; C Kramm; M Nathrath; K Chrzanowska; E Tausch; M Takagi; T Taga; S Constantini; J Loeffen; J Meijerink; S Zielen; G Gohring; B Schlegelberger; E Maass; R Siebert; J Kunz; A E Kulozik; B Worst; D T Jones; S M Pfister; M Zapatka; P Lichter; A Ernst
Journal:  Leukemia       Date:  2017-02-15       Impact factor: 11.528

3.  Dopa-Responsive Dystonia and Chorea as a Presenting Feature in Ataxia-Telangiectasia.

Authors:  Sarah Thompson; Anand Iyer; Philip Byrd; Malcolm Taylor; Stefan Spinty
Journal:  Mov Disord Clin Pract       Date:  2014-06-11

4.  Late-onset ataxia telangiectasia.

Authors:  Laurence Newrick; Noor Sharrack; Marios Hadjivassiliou
Journal:  Neurol Clin Pract       Date:  2014-08

5.  Utility of DNA, RNA, Protein, and Functional Approaches to Solve Cryptic Immunodeficiencies.

Authors:  Margot A Cousin; Matthew J Smith; Ashley N Sigafoos; Jay J Jin; Marine I Murphree; Nicole J Boczek; Patrick R Blackburn; Gavin R Oliver; Ross A Aleff; Karl J Clark; Eric D Wieben; Avni Y Joshi; Pavel N Pichurin; Roshini S Abraham; Eric W Klee
Journal:  J Clin Immunol       Date:  2018-04-18       Impact factor: 8.317

Review 6.  Ataxia-telangiectasia - A historical review and a proposal for a new designation: ATM syndrome.

Authors:  Hélio A G Teive; Adriana Moro; Mariana Moscovich; Walter O Arruda; Renato P Munhoz; Salmo Raskin; Tetsuo Ashizawa
Journal:  J Neurol Sci       Date:  2015-05-29       Impact factor: 3.181

7.  Novel mutations in ataxia telangiectasia and AOA2 associated with prolonged survival.

Authors:  Marie Y Davis; C Dirk Keene; Phillip D Swanson; Conor Sheehy; Thomas D Bird
Journal:  J Neurol Sci       Date:  2013-09-17       Impact factor: 3.181

8.  Brain glucose metabolism in adults with ataxia-telangiectasia and their asymptomatic relatives.

Authors:  Nora D Volkow; Dardo Tomasi; Gene-Jack Wang; Yana Studentsova; Brad Margus; Thomas O Crawford
Journal:  Brain       Date:  2014-04-17       Impact factor: 13.501

Review 9.  Phenotypes and genotypes of the chromosomal instability syndromes.

Authors:  Zhan-He Wu
Journal:  Transl Pediatr       Date:  2016-04

10.  Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in Genome Integrity and Cancer.

Authors:  Chun-Chin Chen; Weiran Feng; Pei Xin Lim; Elizabeth M Kass; Maria Jasin
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.